comprehensive -WSS

comprehensive

author：hotspot 2025-10-06 17:35:36 - browse：95727

A man enters the Regeneron Clinic at a monoclonal antibody treatment site in Pembroke Pines, Florida – politics and policy coverage from STAT — Regeneron agreed to price limits for a new Covid-19 drug that will be developed in partnership with the Department of Health and Human Services. CHANDAN KHANNA/AFP via Getty Images

WASHINGTON — A groundbreaking clause in a new deal between the Department of Health and Human Services and the pharmaceutical company Regeneron marks the first time the Biden administration has directly used its leverage to challenge drugmakers’ list prices, experts told STAT.

The contract between Regeneron and the government requires that the list price for a future monoclonal antibody drug to prevent Covid-19 is the same or lower in the United States as in other high-income countries. The release doesn’t explain which countries the government will be comparing prices with, or how pricing data will be determined.

The deal was part of the White House’s Project NextGen initiative, which includes $5 billion in new vaccines and therapies. HHS announced that it is spending $326 million to help Regeneron develop a new monoclonal antibody to prevent Covid-19. Regeneron in January announced plans to start testing a potentially variant-proof antibody, which is set to go into clinical trials later this year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

entertainment

hotspot

WSS

How the Dana

WHO recommends dropping component of many flu vaccines

Listen: Who gets the credit for GLP

Childhood cancer progress stalls for Black, Hispanic kids: Report

Shingles, which affected Dianne Feinstein, is on the rise

PBM reforms clear House panel

Wikipedia

comprehensive

focus

The high cost of giving birth even with insurance

Why medical students are struggling with mental health

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Medicare drug price negotiation program allowed for now

Psychedelics group wrestles with new pharma identity

How the Dana

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Shingles, which affected Dianne Feinstein, is on the rise

How to save PrEP access — and even expand it

After a drawn out lobbying fight, ARPA

Wikipedia

How the Dana

Cigna to pay $172 million to settle Medicare Advantage fraud probe

Listen: Who gets the credit for GLP

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

Why do women spend more than men on medical expenses?

Would Medicare drug price negotiations stall in a shutdown?

explore

entertainment

hotspot

Wikipedia